
IKT
Healthcare · Biotechnology · $213.2M market cap
$1.52-0.01 (-0.7%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -2.4% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | Time not confirmed | -0.11 | -0.10 | +9.1% |
| Aug 11, 2026 | After the close | -0.09 | -0.11 | -22.2% |
| May 13, 2026 | Time not confirmed | -0.09 | -0.10 | -5.7% |
| Mar 26, 2026 | After the close | -0.12 | -0.09 | +25.0% |
| Nov 14, 2025 | After the close | -0.13 | -0.13 | 0.0% |
| Aug 14, 2025 | After the close | -0.08 | -0.11 | -37.5% |
| May 14, 2025 | After the close | -0.09 | -0.15 | -66.7% |
| Mar 25, 2025 | Before the open | -0.09 | -0.17 | -101.7% |
| Nov 14, 2024 | Before the open | -0.48 | -0.65 | -35.4% |
| Aug 14, 2024 | After the close | -0.67 | -0.66 | +1.5% |
| May 15, 2024 | After the close | -0.79 | -0.73 | +7.6% |
| Mar 27, 2024 | After the close | -0.85 | -0.64 | +24.7% |
| Nov 14, 2023 | After the close | -1.12 |
Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics to modify the course of cardiopulmonary diseases, with a primary focus on pulmonary arterial hypertension (PAH), a progressive, life-threatening disease characterized by pulmonary vascular remodeling and elevated pulmonary vascular resistance. It offers IKT-001, a novel oral prodrug of imatinib mesylate…
| -0.86 |
| +23.2% |
| Aug 14, 2023 | After the close | -0.92 | -1.11 | -20.7% |
| May 15, 2023 | Before the open | -0.90 | -0.96 | -6.7% |
| Mar 31, 2023 | Before the open | -0.19 | -0.18 | +5.3% |
| Nov 14, 2022 | After the close | -0.18 | -0.18 | 0.0% |
| Aug 12, 2022 | After the close | -0.19 | -0.18 | +5.3% |
| May 16, 2022 | After the close | -0.17 | -0.18 | -5.9% |
| Mar 31, 2022 | After the close | -0.17 | -0.20 | -17.6% |
| Nov 15, 2021 | After the close | -0.14 | -0.18 | -28.6% |
| Aug 16, 2021 | After the close | -0.38 | -0.22 | +42.1% |
| May 17, 2021 | After the close | — | -0.26 | — |
| Mar 31, 2021 | After the close | — | -0.15 | — |
| Dec 4, 2020 | Time not confirmed | — | -0.08 | — |
| Sep 30, 2020 | Time not confirmed | — | -0.06 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -0.05 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.07 | — |
| Dec 31, 2019 | Time not confirmed | 0.00 | -0.05 | — |
| Sep 30, 2019 | Time not confirmed | 0.00 | -0.15 | — |
| Jun 30, 2019 | Time not confirmed | 0.00 | -0.29 | — |
| Mar 31, 2019 | Time not confirmed | 0.00 | -0.21 | — |
| Oct 16, 2018 | Time not confirmed | — | -0.10 | — |
| Mar 31, 2018 | Time not confirmed | 0.00 | -0.02 | — |